Work

Phase II study of irinotecan plus panitumumab as second-line therapy for patients with advanced esophageal adenocarcinoma (EAC).

Year: 2010

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2010.28.15_suppl.tps206

Authors: A. Atasoy, H. Yoon, A. M. Egloff, R. L. Ferris, A. H. Zaidi, B. Hough, A. A. Forastiere, B. A. Jobe, K. S. Nason, M. K. Gibson

Language: English

Topic: Esophageal Cancer Research and Treatment

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7902152

Cites:

Cited by:

Related to: 10